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Objective: To test the hypothesis that the spondyloepiphyseal dysplasia congenita (sedc) heterozygous
(sedc/þ) mouse, a COL2A1 mutant, is a model for the study of osteoarthritis (OA) in the absence of
dwarﬁsm and to investigate the presence of HtrA1, Ddr2, and Mmp-13 and their possible involvement in
a universal mechanism leading to OA.
Design: Whole mount skeletons of adult animals were analyzed to determine whether sedc/þ mice
exhibit dwarﬁsm. To characterize progression of osteoarthritic degeneration over time, knee and
temporomandibular joints from sedc/þ and wild-type mice were analyzed histologically, and severity of
articular cartilage degradation was graded using the Osteoarthritis Research Society International
(OARSI) scoring system. Immunohistochemistry was used to detect changes in expression of HtrA1, Ddr2,
and Mmp-13 in articular cartilage of knees.
Results: As previously reported, the sedc/þ skeleton morphology was indistinguishable fromwild type, and
skeletal measurements revealed no signiﬁcant differences. The sedc/þ mouse did, however, show signiﬁ-
cantly higherOARSI scores in knee (9,12 and 18months) and temporomandibular joints at all ages examined.
Histological staining showed regions of proteoglycan degradation as early as 2 months in both temporo-
mandibular and knee joints of themutant. Cartilage ﬁssuring and erosionwere observed to begin between 2
and 6 months in temporomandibular joints and 9 months in knee joints from sedc/þ mice. Immunohisto-
chemistry of mutant knee articular cartilage showed increased expression of HtrA1, Ddr2, and Mmp-13
compared to wild type, which upregulation preceded ﬁbrillation and ﬁssuring of the articular surfaces.
Conclusions: With regard to skeletal morphology, the sedc/þ mouse appears phenotypically normal but
develops premature OA as hypothesized. We conclude that the sedc/þ mouse is a useful model for the
study of OA in individuals with overtly normal skeletal structure and a predisposition for articular
cartilage degeneration.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a growing problem in the United States as
the population ages, affecting a reported 27 million people1.
Articular cartilage acquires its tensile strength from a dense
meshwork of collagen ﬁbrils in the extracellular matrix (ECM),
including types II, IX, and XI collagen2. In addition, type VI collagen
is present in the region immediately surrounding chondrocytes, the
pericellular matrix (PCM), and may help the chondrocytes attach toto: Robert E. Seegmiller,
y, Brigham Young University,
01-422-0700.
eegmiller).
s Research Society International. Pthe framework of the ECM3. An assortment of other ECM and PCM
proteins and proteoglycans such as aggrecan, decorin, biglycan,
ﬁbromodulin, cartilage oligomeric matrix protein (COMP),
ﬁbronectin, and matrilin-3 interact with the collagen network in
the ECM to provide cartilage with its resistance to compression3.
Several different human chondrodysplasias are caused by muta-
tions in the cartilage collagen genes. These include spondyloepiphy-
seal dysplasia (SED), spondyloepimetaphyseal dysplasia
(SEMD), oto-spondylo-megaepiphyseal dysplasia (OSMED), multiple
epiphyseal dysplasia (MED), Kniestdysplasia,Marshall syndrome, and
Stickler syndrome4. These chondrodysplasia syndromes all feature
varying degrees of disproportionately short stature, craniofacial
abnormalities, hearing loss, eye problems, and cleft palate and in
some, degenerative changes in articular cartilage. For example, in anublished by Elsevier Ltd. All rights reserved.
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humans, the expression in cartilage of a type II collagen mutation at
the protein level has been documented5. Our biochemical studies
usingmousemodels of chondrodysplasia have also shown that when
defective type II collagen6 ordefective typeXI collagen7 is deposited in
the matrix of diseased cartilage, collagen ﬁbrils are abnormal and
premature degeneration of articular cartilage results8e10.
While chondrodysplasia models of OA have been important in
advancing our understanding of OA, the majority of OA cases in
humans are not associated with any recognizable features of chon-
drodysplasia. This raises the question of whether the cartilage
collagen genes play a signiﬁcant role in the majority of human OA, or
are only relevant in the minority of cases associated with chon-
drodysplasias. A recent study by Kannu et al.11 demonstrated that, in
fact, at least two different heterozygous point mutations in the triple
helical domain of the COL2A1 gene can cause degenerative joint
disease in humans in the absence of other phenotypic abnormalities.
In the present study, we report OA-like changes in a mouse
model that, like the human families presented by Kannu et al., bears
a mutation in the Col2a1 gene that behaves as a recessive mutation
resulting in no obvious phenotype in the heterozygote. The mouse
mutation was named spondyloepiphyseal dysplasia congenita
(sedc) by Donahue et al.12 because when homozygous it produces
features that resemble themost common clinical phenotypes of SED
congenita in humans. The sedc mutation results from an R992C
substitution within the triple helix of the collagen a1 (II) chains.
Biochemical studies of pepsin extracted collagen clearly show the
presence of disulﬁde bonded collagen a1 (II) chains in adult sedc
mouse rib cartilage and absence in þ/þ (wild type) cartilage (Drs.
D.R. Eyre and R.J. Fernandes, personal communication). In humans,
an analogous mutation R519C in the triple helix of collagen a1 (II)
chain has been shown to cause an inherited form of OA with mild
chondrodysplasia5 and another similar mutation, R789C, also in the
triple helical region ofa1 (II) chains has been shown to cause SEDC13.
Disulﬁde bondedmutant a1 (II) collagen chains, not normally found
in type II collagen, were detected in cartilage from both patients12.
To look for signs of OA in the overtly normal heterozygous sedc
(sedc/þ) mice, we examined knee and temporomandibular joints
over the course of several months and found premature and
progressive OA as demonstrated by loss of proteoglycans in the
articular cartilage ECM,ﬁbrillation of the articular surfaces,ﬁssuring
of the cartilage, and ultimately separation of decalciﬁed from
calciﬁed articular cartilage. Furthermore, we saw increased levels of
HtrA1, a serine protease that is believed to contribute to OA by
degrading components of the PCM;Ddr2, a cell surface receptor that
binds type II collagen and up regulates Mmp-13 expression; and
Mmp-13, a matrix metalloproteinase proposed to play a key role in
OA progression by digesting type II collagen. Previous studies have
shown that Mmp-13 and Ddr2 knockout mice are resistant to
surgically inducedOA14,15. In the present studywe establish the sedc
heterozygousmouse as amodel of OA and conﬁrm the presence and
possible involvement of HtrA1, Ddr2, and Mmp-13 in its progres-
sion. We conclude that the sedc/þ mouse is a useful model for the
study of OA in individuals with normal skeletal structure who are
predisposed to articular cartilage degeneration.Methods and materials
Experimental animals and genotyping
Mice (<5 per cage) were maintained in 5 8 inches (40 square
inches) cages containing paper bedding, fed a standard mouse diet,
and provided with a 12 h light/12 h dark cycle. All experiments
were approved by the Brigham Young University IACUC.Heterozygous sedc mice (JAX Mice # 003916 The Jackson Labo-
ratory, Bar Harbor, ME) originally derived from a mixed background
comprising C57BL/6J, C3H/HeJ, and AKR/J strains were crossed to
produce the þ/þ and sedc/þ mice used in this study. Animals
were identiﬁed using an ear punch system and DNA for genotyping
was isolated from tail biopsies. Genotyping was performed using
polymerase chain reaction (PCR) ampliﬁcation with the following
primers: forward: TTGGTCCCTCTGGCAAAG; reverse: AACAGGGCC
TGTTTCTCCTG. The ampliﬁed DNA was digested with BtsCI, which
cleaves the mutated nucleotide sequence, and then visualized using
agarose gel electrophoresis12.
Morphometric analysis
Male þ/þ mice (average age 10.2 weeks 2.7) and sedc/þ mice
(average 10.5 weeks 2.5) were euthanized by CO2 inhalation and
eviscerated, soft tissues were removed in 1% KOH, and skeletons
were stained in a 1% KOH, 0.004% Alizarin red solution. Specimens
were cleared in a graded glycerol series (50%, 80% and 100%). The
length, condylar and midshaft widths of the femor, and the length,
condylar, midshaft and malleolar widths of the tibia were measured
from both hind limbs with a dial caliper (Tresna, Essen, Germany) to
0.01 mm. Length from the nose to the base of the tail was also
measured. The sample size was n¼ 6 for þ/þ controls and n¼ 4 for
sedc/þmice. Statistical analysis was done using SPSS 18 independent
sample t-test where P-values of <0.01 were considered signiﬁcant.
Tissue processing
Wild-type and sedc/þmice at 2, 6, 9, and 12 months of age were
euthanized by CO2 inhalation, and knees (R & L) and temporoman-
dibular joints were excised and ﬁxed in 4% paraformaldehyde
overnight. The tissues were decalciﬁed in a formic acid solution that
was changed every 2e3 days for a period of 2e3weeks. Tissues were
embedded in parafﬁn wax using an automated tissue processor
(ThermoFisher Scientiﬁc, MA). Parafﬁn blocks were prepared with
the knee joint bent at a 120 angle, with the anterior tibial surface
ﬂush with the cutting surface. TM joints were embedded in parafﬁn
wax with the joint ﬂush with the cutting surface8.
Knee and TM joint blocks were sectioned at 6 mm through the
entire joint from the anterior surface to the posterior. Four to ﬁve
sections were placed per glass microscope slide, yielding approxi-
mately 35e50 slides or approximately 160e225 sections per joint.
Histological analysis
Histopathology was documented by Safranin O and fast green
staining of every sixth slide of 2-, 6-, 9-, and 12-month knee
samples (2 monthsþ/þ, 2 months sedc/þ, 6 monthsþ/þ all n¼ 7, 6
months sedc/þ n¼ 9, 9 months þ/þ n¼ 8, 9 months sedc/þ, 12
months þ/þ, 12 months sedc/þ all n¼ 7) The same was done for 2-,
6-, 9-, and 12-month temporomandibular joints (n¼ 4 for each age
group). In the above analyses, “n” refers to the number of mice from
which joints were examined. Using a light microscope equipped
with a digital camera, photographs of each knee joint were taken at
200 and 400 magniﬁcations.
The articular cartilage in two representative sections from each
stained slide was analyzed using the Osteoarthritis Research
Society International (OARSI) scoring system to quantify the path-
ological state of each joint, with a score of zero representing
unaltered articular cartilage and six representing severe OA. Overall
OARSI scoring was based on an osteoarthritic damage 0e6
subjective scoring system applied to all four quadrants of the
knee16. The OARSI scoring system was applied to the TM joint as
a whole rather than quadrants. Immunohistochemistry and
Fig. 1. Heterozygous sedc skeletons appear morphologically normal compared to þ/þ. Alizarin red-stained skeletons from 3-month-old þ/þ and sedc/þ mice demonstrate that sedc/þ
mice show none of the skeletal changes typically associated with chondrodysplasia and are not morphometrically different from þ/þ.
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demonstrate the universal nature of the OA in the sedc model.
Statistical analysis
Amixedmodels analysis of variance (ANOVA)was performed on
the OARSI score data. The dependent variables were the OARSI
scores for both the knee and TMJ. The independent variables were
age and genotype along with their interaction. Blocking was on
each animal to account for their multiple measures. Post-hoc t-tests
were performed to determine differences in genotype at each age,
P-values of <0.05 were considered signiﬁcant.Table I
sedc/þ skeletons are not morphometrically different from þ/þ
Measurement (mm) þ/þ (n¼ 6) sedc/þ (n¼ 4)
Femur length 14.8 0.5 14.6 0.7
Femoral midshaft width 1.5 0.5 1.5 0.3
Tibia length 18.9 0.6 18.8 0.7
Tibial condylar width 3.0 0.2 3.0 0.1
Tibial midshaft width 1.1 0.1 1.2 0.1
Tibial malleolar width 1.9 0.2 1.9 0.1
Nose to base of tail 82.6 1.2 80.8 1.4
Mean standard deviation; n¼ number of mice.Immunohistochemical analysis
Immunohistochemistry was performed on sections of mouse
knee joints from every sixth slide from 4 þ/þ and 4 sedc/þ animals
at 2-, 6-, 9-, and 12-month time points. Separate slides were stained
with antibodies against HtrA1, Ddr2, Mmp-13 and type VI collagen.
Each slide was deparafﬁnized and then blocked with bovine serum
albumin for 1 h. Primary antibodies against HtrA1 (ab38611)
(Abcam, Cambridge, MA), against Ddr2 (SC-8989) (Santa Cruz
Biotechnology, Santa Cruz, CA), against Mmp-13 (AB8120)
(Chemicon, Temecula, CA) and against type VI collagen (SC-9855)
(Santa Cruz Biotechnology, Santa Cruz, CA). All antibodies were
diluted 1:200, applied to specimens, and incubated overnight at
4 C. On the second day, samples were rinsed with PBS and then
incubated with an avidin/biotin ABC mix (Vectastain elite ABC Kit).
Slides were rinsed again with PBS and incubated with biotinylated
secondary antibody. After a third rinse, a color reaction wasinitiated using a peroxidase substrate (Vector Labs, NovaRED).
Negative controls were prepared by staining without the addition
of primary antibody. Differences in staining intensity were
compared qualitatively with þ/þ controls. Counting of stained cells
was performed using ImageJ (NIH, Bethesda, MD).
Results
The sedc/þ mouse shows normal skeletal morphology
Consistent with that previously reported by Donahue et al.,
when compared with þ/þ controls, the adult sedc/þ mouse
skeleton showed normal morphology and size (Fig. 1). Morpho-
metric analysis of the femor and tibia and other skeletal structures
revealed no statistically signiﬁcant differences between sedc/þ and
controls, and the overall length of the mice from the tip of the nose
to the base of the tail was also similar to control (Table I).
Fig. 2. Osteoarthritic degradation of cartilage is accelerated in sedc/þ compared toþ/þ knee joints. Large panel images were captured at 200magniﬁcation and show the temporal
progression of OA in þ/þ and sedc/þ knee joints at the time points indicated. Insets are 400 magniﬁcations. In 2-month-old sedc/þ joints, a localized region of proteoglycan
degradation is seen in the superﬁcial zone, as demonstrated by decreased Safranin O staining (arrow). Six-month-old sedc/þ joints show increased Safranin O staining of the PCM,
accompanied by decreased Safranin O staining in the interterritorial matrix region suggestive of proteoglycan degradation (400 insets). Proteoglycan degradation is also seen in
the superﬁcial zone (arrow). In joints from 9-, 12- and 18-month-old sedc/þ animals, large regions of the superﬁcial zone are entirely lacking proteoglycan staining (arrows).
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We examined both right and left knees. No histological differ-
ence was observed between left and right knees. For purposes of
uniformity, all pictures are of right knees only.
Wild-type controls showed normal histological staining of the
knee articular cartilage (Fig. 2). Only slight staining with Safranin O
was observed in the PCM whereas in the interterritorial ECM
intense staining was seen in the superﬁcial zone and moderate
staining was observed in the deep zone as an overall trend in theþ/
þ age-matched controls. Decreased Safranin O staining of þ/þ
samples occurred as animals aged starting sometime between 2
and 6 months primarily in the deep zone adjacent to the middle
zone. A decrease of proteoglycan staining was seen in the superﬁ-
cial zone of þ/þ mice at 9 months of age.
Histological analysis of sedc/þ knee joints revealed a signiﬁcant
increase of Safranin O stain in the PCM compared to controls
(Fig. 2). This abnormally intense Safranin O staining in the PCM
indicates an increased quantity of proteoglycan, ﬁrst observed at 6
months, which gradually decreased as animals aged. In spite of this
increased quantity of proteoglycan, localized decreases in Safranin
O staining were observed in the ECM of the superﬁcial zone rep-
resenting possible lesions in the articular cartilage of sedc/þ mice
starting as early as 2 months (Fig. 2). The regions of decreased
Safranin O staining in the superﬁcial zone expanded and deepened
in older sedc/þ animals, with the most signiﬁcant signs of proteo-
glycan degradation appearing at 12 months of age.
The OARSI scoring of sections from þ/þ and sedc/þ knee joints
revealed that þ/þmice showed a slight progression of OAwith age
until 9months inwhich case progressionwas signiﬁcantly elevated.
However, OA in sedc/þ temporomandibular joints was more severe
thanþ/þmice at all ages examined [Fig. 3(A) and (B), respectively].Fig. 3. OARSI scoring demonstrated a signiﬁcant increase in the severity of OA in sedc/þ
compared to þ/þmice at 9, 12 and 18 months in knee joints [(A) n¼ 7e9 per group] and
2, 6, 9 and 12 months in temporomandibular joints [(B) n¼ 4 per group]. The “n” refers to
the number of mice. P< 0.05.Evidence of OA in the sedc/þ temporomandibular joint
Analysis of Safranin O and fast green stained temporomandib-
ular joints showed that þ/þ joints had intense Safranin O staining
in both superﬁcial and deep zones at 2 months, which was
decreased in the superﬁcial zone at 6 months of age and continued
to decrease at later time points (Fig. 4). In sedc/þ temporoman-
dibular joints at 2 months of age, proteoglycan staining in the
superﬁcial zone was less intense compared with controls, and was
seen to decrease until 12 months. In sedc/þ joints at 6 and 9
months, increased Safranin O staining was apparent in the PCM but
was decreased in the interterritorial ECM. By 12 months, Safranin O
staining was nearly absent in both superﬁcial and deep zones of
sedc/þ temporomandibular joints, except in the PCM around some
chondrocytes.
The þ/þ temporomandibular joint surface was intact at 2 and 6
months, and showed some mild ﬁssuring at 9 and 12 months. The
sedc/þ temporomandibular joint showed mild ﬁssuring at 6
months of age and deep ﬁssures with separation of uncalciﬁed from
calciﬁed articular cartilage at 9 and 12 months of age (Fig. 4). The
OARSI scoring showed that OA was signiﬁcantly more advanced in
sedc/þ than in control temporomandibular joints at all time points
examined [Fig. 3(B)].
HtrA1, Ddr2, and Mmp-13 are upregulated in sedc/þ knee joint
cartilage
Immunohistochemical staining for HtrA1, Ddr2, and Mmp-13
was virtually absent in knee articular cartilage from 2- and 6-
month-oldþ/þ controls. At 9 months, HtrA1 staining was apparent
in two of the four samples, and at 12 months, all three proteins
were mildly elevated in three of the four control animals. In sedc/þ
knee samples, HtrA1 and Ddr2 stainingwas detected at 2months of
age, but Mmp-13 was not detectable. By 6months, HtrA1, Ddr2, and
Mmp-13 were all markedly increased in sedc/þ samples (Fig. 5). At
9 months, the expression of Ddr2 and Mmp-13 was elevated in
sedc/þ compared to controls, but HtrA1 levels were comparable to
controls. At 12 months, only Mmp-13 expression remained
elevated compared to controls.
In addition to observing an increase in staining intensity, we
also noted a signiﬁcant difference in the number of cells staining for
HtrA1, Ddr2 and Mmp-13 in sedc/þmice compared to þ/þ controls
at 6 months (Table II). The number of cells per unit area was not
signiﬁcantly different between þ/þ and sedc/þ in any of the joints
examined (Table II).
Cells expressing HtrA1 show less pericellular type VI collagen
staining
Knee articular cartilage from 6-month þ/þ and sedc/þ animals
was stained by immunoﬂuorescence using antibodies against HtrA1
(green) and type VI collagen (red). Consistent with the results shown
in Fig. 5, sedc/þ samples showed increased HtrA1 staining compared
to þ/þ [compare Fig. 6(E) to Fig. 6(B)]. This increased HtrA1 staining
correlated with decreased type VI collagen in the PCM, as demon-
strated by red staining that appeared to be primarily intracellular in
sedc/þ [Fig. 6(D)], rather than surrounding the cells in a ring as was
visible in þ/þ [Fig. 6(A), arrows]. The same trend was observed at 9
months (data not shown).
Discussion
We have demonstrated that sedc/þmice show evidence of OA in
histological analyses of knee and temporomandibular joints. In
both joints of the mutant, decreased proteoglycan staining of the
Fig. 4. Osteoarthritic degradation of cartilage is accelerated in sedc/þ compared to þ/þ TM joints. The TM joint in sedc/þ animals showed mild signs of proteoglycan degradation as
early as 2 months. Fissuring was seen in sedc/þ joints at 6, 9, and 12 months (arrows). At 12 months of age, ﬁssuring and separation of decalciﬁed from calciﬁed cartilage were
severe, and Safranin O staining was only detectable in the PCM of a limited number of chondrocytes of sedc/þ mice. Pictures were taken at 100 magniﬁcation to visualize the
whole TM joint.
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Fig. 5. Six-month-old sedc/þ mice show detectable HtrA1, Ddr2, and Mmp-13. Samples were stained with antibodies against HtrA1, Ddr2, and Mmp-13. Pictures were taken at
200 magniﬁcations with the insets taken at 400 magniﬁcations. All three OA-biomarkers are present in the sedc/þ animal and virtually absent in þ/þ controls.
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time points, the frequency of surface ﬁbrillations increased and the
intensity of proteoglycan staining decreased, except in the region
immediately surrounding chondrocytes, the PCM, where staining
intensity increased. By 12 months, ﬁssures were observed and
separation of decalciﬁed from calciﬁed cartilagewas present in four
of the four temporomandibular joints from sedc/þ animals. While
the earliest signs of OA were present in both knee and temporo-
mandibular joints at 2 months, our observations suggest that
cartilage degradation progresses more rapidly in the temporo-
mandibular than knee joints of both the sedc/þ and þ/þ animals
(Fig. 3). This may be because mice can choose to curtail their
movement but not to stop eating. Hence the temporomandibular
joint is used more than the knee. Alternatively, it could be that the
cartilage in the temporomandibular joint is inherently different
than that in the knee. We are currently examining these
hypotheses.
The increased proteoglycan staining in and around the sedc/þ
PCM was particularly noticeable at the 6-month time point in both
knee and temporomandibular joints. Fissuring was also apparent atTable II
sedc/þ cells stained with biomarkers were signiﬁcantly increased compared withþ/þ
þ/þ (n¼ 4) sedc/þ (n¼ 4)
HtrA1
Tibia total cells 124 13 130 8
% Tibia labeled cells 8 48*
Femor total cells 112 9 106 4
% Femor cells labeled 6 47*
Ddr2
Tibia total cells 135 5 124 4
% Tibia labeled cells 8 49*
Femor total cells 116 3 111 5
% Femor cells labeled 5 49*
Mmp-13
Tibia total cells 126 14 135 9
% Tibia labeled cells 4 54*
Femor total cells 135 9 110 5
% Femoral cells labeled 2 54*
*P< 0.0001; mean standard deviation; n¼ number of mice.the same time point in temporomandibular joints, while knee
joints showed less severe damage. This increased proteoglycan
staining in the immediate vicinity of chondrocytes suggests that
the cells responded to damage in the ECM by increasing proteo-
glycan synthesis.
We have demonstrated herein that OA occurs in sedc/þ animals
with overtly normal skeletal structure and no evidence of the
disproportionately short stature that typiﬁes most chon-
drodysplasias in humans and mice. This shows that type II collagen
mutations that do not cause abnormal skeletal phenotypes can still
lead to degeneration of the articular cartilage. This observation is
important because past research linking relatively rare chon-
drodysplasia/OA syndromes to cartilage collagen gene mutations
has suggested that cartilage collagen mutations are not likely to be
a common cause of OA in the general human population17. Our
work suggests otherwise, and it is consistent with the recent report
by Kannu et al.11 that two different glycine substitution mutations
in the triple helical domain of human type II collagen can predis-
pose individuals to early onset OA with no other characteristics of
chondrodysplasia. The sedc heterozygous mouse, therefore, is
a useful mouse model for the study of OA caused by non-dominant
mutations that lead to overtly normal skeletal phenotypes.
OA researchers in recent years have taken notice of HtrA1,
a member of the high temperature requirement family of serine
proteases. HtrA1 levels are elevated in synovial ﬂuid from OA
patients, and HtrA1 is known to digest severalmajor components of
the articular cartilage PCM including aggrecan, decorin, ﬁbromo-
dulin, ﬁbronectin, and biglycan18e22. The PCM has been shown to
be integral in the biomechanical environment of the
chondrocyte23e25. In the cho/þ mouse, which bears a premature
termination mutation in the Col11a1 type XI collagen gene that is
associated with premature OA, chondrocytes with increased HtrA1
immunostaining were shown to lack pericellular type VI collagen
staining26. Those cells also showed increased expression of Ddr2,
a cell membrane receptor that binds native type II collagen and, in
response, induces expression of the matrix metalloproteinase,
Mmp-13, which degrades type II collagen26e31.
Based on these observations, Polur et al.26 proposed a model for
a potential molecular pathway of articular cartilage degeneration
Fig. 6. Increased HtrA1 staining in 6-month sedc/þ animals coincides with decreased type VI collagen staining in the PCM. Type VI collagen staining (A) and HtrA1 staining (B) of
a 6-month þ/þ tibia. (C) Merge of (A) and (B). Type VI collagen staining (D) and HtrA1 staining (E) of a 6-month sedc/þ tibia. HtrA1 staining of a 6-month sedc/þ tibia surface (E). (F)
Merge of (D) and (E).
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on observations in both genetic and surgical/injury murine models
of OA, that HtrA1-mediated degradation of proteins in the PCMmay
be one of the early steps in the pathogenesis of OA. Disruption of
the PCM could position type II collagen ﬁbrils, which are normally
separated from chondrocytes by a thin layer of PCM, into direct
contact with Ddr2 receptors. Because Ddr2 signaling leads to
upregulation of both Ddr2 andMmp-13, it may initiate a downward
spiral of cartilage degradation27,32,33. This model is supported by
a recent study showing that Mmp-13 as well as Ddr2 deﬁcient mice
are resistant to genetically and surgically induced OA14,15.
The immunohistochemical results presented herein coupled
with histopathological changes in the sedc/þ mutant suggest that
the articular cartilage degeneration we have observed in sedc/þ
mice is consistent with the model proposed by Polur et al. At 2
months of age, when only small regions of proteoglycan degrada-
tion in the superﬁcial zone were apparent, HtrA1 and Ddr2 were
detectable in sedc/þ knees. By 6 months, when proteoglycan
degradation was more widespread and chondrocytes appeared to
have increased their proteoglycan secretion to compensate,
Mmp-13 was easily detectable as well. In þ/þ knee joints, HtrA1
was not detectable until 9months, and Ddr2 andMmp-13 elevation
followed at 12 months of age. Our work validates that which has
been previously done showing the presence of HtrA1, Ddr2, and
Mmp-13 inmutant and surgically induced OAmousemodels and in
human OA patients, in comparison to the absence thereof in the þ/
þ controls14,15,20,26,27,34e36. This mounting evidence suggests that
these three proteins are involved in the pathogenesis of OA inde-
pendent of the event or underlying cause that triggers the onset of
the disease.
In conclusion, we submit that the sedc/þ mouse is a useful new
model of OA because, unlike models or conditions that express
dwarﬁsm in the heterozygote (mouse Dmm/þ and human Sticklersyndrome), it exhibits normal skeletal stature and structure.
The sedc/þ mouse supports the hypothesis that OA cases in the
general population may be triggered or exacerbated by cartilage
collagen mutations, speciﬁcally type II collagen mutations, that
have subtle effects on the structure of cartilage. An important focus
in the ﬁeld of OA research at present is determining whether the
different forms of OA that develop as a result of genetic predispo-
sition, chronic joint stress, or acute injury all follow the same
molecular pathway of articular cartilage degradation once OA is
initiated. HtrA1, Ddr2, and Mmp-13 are potential components of
such a common molecular pathway. Previous work has demon-
strated their elevation in surgically induced OA and in a genetic
chondrodysplasia mouse model35,36. Here we have demonstrated
that HtrA1, Ddr2, and Mmp-13 are also elevated in a non-dwarﬁsm
mouse model of OA. The cartilage degradation pathway involving
HtrA1, Ddr2, and Mmp-13 is a mechanism that merits further
investigation, especially because it points to Ddr2 as a potential
target for therapeutic intervention. The sedc/þmousewill be useful
to compare with chondrodysplasia, surgical, and other genetic
models of OA to further establish possible common molecular
pathways, and ultimately, to develop novel therapeutic approaches.
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